PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Stroke D020521 32 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Fetal Weight D020567 12 associated lipids
Parkinsonian Disorders D020734 20 associated lipids
Coronary Restenosis D023903 10 associated lipids
Tauopathies D024801 6 associated lipids
Mastocytosis, Systemic D034721 1 associated lipids
Decapitation D049248 2 associated lipids
Graves Ophthalmopathy D049970 3 associated lipids
Atherosclerosis D050197 85 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Watanabe K et al. Biosynthesis of prostaglandin F2 alpha from prostaglandins H2 and D2 by an apparently homogeneous enzyme. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936081
Liston TE et al. Prostaglandin D2 is metabolized in humans to 9 alpha,11 beta-prostaglandin F2, a novel biologically active prostaglandin. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936123
Toda N et al. Neuroeffector actions of prostaglandins on isolated arteries. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936153
Ueno R et al. Prostaglandin D2: a cerebral sleep-regulating substance in rats. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936173
pmid:29402808
pmid:29463843
Frölich JC et al. Advances in the analysis of eicosanoids by ELISA and GC/MS/MS. 1986 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2949561
Tilden SJ et al. Effects of OKY 1581 on bronchoconstrictor responses to arachidonic acid and PGH2. 1987 J. Appl. Physiol. pmid:2954941
Seibert K et al. 9 alpha, 11 beta-prostaglandin F2: formation and metabolism by human lung and contractile effects on human bronchial smooth muscle. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2959045
Roberts LJ et al. PGD2 is transformed by human coronary arteries to 9 alpha, 11 beta-PGF2, which contracts human coronary artery rings. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2959090
Watanabe K et al. Stereospecific conversion of prostaglandin D2 to 9 alpha, 11 beta-prostaglandin F2 and prostaglandin H2 to prostaglandin F2 alpha by PGF synthetase. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2959094
Wendelborn DF et al. Isomeric prostaglandin F2 compounds: a new family of eicosanoids produced in vivo in humans. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2959099
Pugliese G et al. 9 alpha, 11 beta-prostaglandin F2: a new prostanoid with selective biosynthesis and unique biological activity. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2959104
Robinson C et al. Effects of inhaled 9 alpha, 11 beta-prostaglandin F2 on airway function in man. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960146
Roberts LJ Recent metabolic findings bring into question the reliability of existing methods for quantification of PGF2 alpha and its metabolites in human biological fluids. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960165
Prakash C et al. Synthesis of putative prostaglandin D2 metabolites. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960191
Watanabe Y et al. Synthesis of 11C-labeled prostaglandins and positron emission tomography studies using the rhesus monkey. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960207
Hayaishi O et al. Prostaglandin D2 induces sleep when infused into the cerebral ventricle of conscious monkeys. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960208
Narumiya S and Fukushima M Active transport and cellular accumulation of cyclopentenone prostaglandins: a mechanism of prostaglandin-induced growth inhibition. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960214
Ono K et al. Suppressive effects of various antitumor prostaglandin derivatives on the activity levels of DNA polymerases in human cultured tumor cells. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960215
Beasley R et al. Cholinergic-mediated bronchoconstriction induced by prostaglandin D2, its initial metabolite 9 alpha,11 beta-PGF2, and PGF2 alpha in asthma. 1987 Am. Rev. Respir. Dis. pmid:2960256
Koh T et al. Serotonin involvement in the inhibition of luteinizing hormone (LH) release induced by prostaglandin D2 (PGD2) in castrated male rats. 1988 Eur. J. Pharmacol. pmid:2969338
Broide DH et al. Functional and biochemical characterization of rat bone marrow derived mast cells. 1988 J. Immunol. pmid:2974057
Bhattacharya SK and Parmar SS Prostaglandin D2 inhibits pentylenetetrazole-induced convulsions in rats by a serotonin-mediated mechanism. 1987 Pharm. Res. pmid:2977646
Robinson C and Holgate ST Mast cell-dependent inflammatory mediators and their putative role in bronchial asthma. 1985 Clin. Sci. pmid:2981650
Westcott JY and Murphy RC Effect of alcohols on arachidonic acid metabolism in murine mastocytoma cells and human polymorphonuclear leukocytes. 1985 Biochim. Biophys. Acta pmid:2982416
Imashuku S et al. Tumor differentiation--application of prostaglandins in the treatment of neuroblastoma. 1985 Prog. Clin. Biol. Res. pmid:2986176
Makino S [Physiological and pharmacological actions of prostaglandins and related substances: inflammation and allergy]. 1985 Nippon Rinsho pmid:2989584
Siegl AM and Daly JW Receptor (norepinephrine), P-site (2',5'-dideoxyadenosine), and calcium-mediated inhibition of prostaglandin and forskolin-activated cyclic AMP-generating systems in human platelets. 1985 J Cyclic Nucleotide Protein Phosphor Res pmid:2991349
Förstermann U et al. Studies on the mechanism of central cardiovascular and temperature responses to prostaglandin D2. 1985 Prostaglandins Leukot Med pmid:2991946
Hamid S and Whittle BJ Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets. 1985 Br. J. Pharmacol. pmid:2992652
Narumiya S and Toda N Different responsiveness of prostaglandin D2-sensitive systems to prostaglandin D2 and its analogues. 1985 Br. J. Pharmacol. pmid:2992661
Watanabe Y et al. Specific bindings of prostaglandin D2, E2 and F2 alpha in postmortem human brain. 1985 Brain Res. pmid:2994820
Bertelé V et al. Refractoriness of platelets to prostaglandins after infusion in rabbits. 1985 J. Lab. Clin. Med. pmid:2997353
Dutta-Roy AK et al. Prostacyclin stimulation of the activation of blood coagulation factor X by platelets. 1986 Science pmid:3001935
Fortini A et al. Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets. 1985 Thromb. Res. pmid:3001968
Wasserman SI The mast cell and theophylline in asthma. 1985 Am. J. Med. pmid:3002176
Bushfield M et al. Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP. 1985 Biochem. J. pmid:3002327
Ichikawa A et al. Up-regulation of prostaglandin D2 receptors by agonist binding to beta-adrenoceptors in rabbit platelets. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3004152
Eling TE et al. Oxidation of glutathione to its thiyl free radical metabolite by prostaglandin H synthase. A potential endogenous substrate for the hydroperoxidase. 1986 J. Biol. Chem. pmid:3007487
Kuno S et al. Prostaglandin E2, a seminal constituent, facilitates the replication of acquired immune deficiency syndrome virus in vitro. 1986 Proc. Natl. Acad. Sci. U.S.A. pmid:3010301
Hattori Y and Levi R Effect of PGD2 on cardiac contractility: a negative inotropism secondary to coronary vasoconstriction conceals a primary positive inotropic action. 1986 J. Pharmacol. Exp. Ther. pmid:3012066
Tsao CJ et al. In-vitro effects of antineoplastic prostaglandins on human leukemic cell growth and normal myelopoiesis. 1986 Leuk. Res. pmid:3012210
Halenda SP et al. Effects of thrombin, phorbol myristate acetate and prostaglandin D2 on 40-41 kDa protein that is ADP ribosylated by pertussis toxin in platelets. 1986 FEBS Lett. pmid:3015684
Todo S et al. Cell kinetic studies of PGD2 cytotoxicity on the in vitro growth of human neuroblastoma. 1986 Prostaglandins Leukot Med pmid:3016753
Bhattacharya SK The antinociceptive effect of intracerebroventricularly administered prostaglandin D2 in the rat. 1986 Psychopharmacology (Berl.) pmid:3016786
Hamid-Bloomfield S and Whittle BJ Prostaglandin D2 interacts at thromboxane receptor-sites on guinea-pig platelets. 1986 Br. J. Pharmacol. pmid:3017497
Ruzicka T et al. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. 1986 J. Invest. Dermatol. pmid:3018086
Shalit M et al. New role for heparan sulfate: regulator of leukotriene generation in mouse E-mast cells. 1986 Life Sci. pmid:3018403
Zavoico GB et al. Regulation of intracellular pH in human platelets. Effects of thrombin, A23187, and ionomycin and evidence for activation of Na+/H+ exchange and its inhibition by amiloride analogs. 1986 J. Biol. Chem. pmid:3020026
Viganò T et al. Stimulus-related difference in the formation of leukotrienes and PGD2 after immunological and non-immunological challenge of human lung parenchyma "in vitro". 1986 Prostaglandins Leukot Med pmid:3020580
Koshihara Y and Kawamura M Inhibitory effect of prostaglandin D2 on DNA synthesis in nuclei. 1986 Prostaglandins Leukot Med pmid:3020589
Jaschonek K et al. The binding of 6-oxo-prostaglandin E1 to platelet prostanoid receptors. 1986 Prostaglandins Leukot Med pmid:3020591
Inokuchi A and Oomura Y Effects of prostaglandin D2 on the activity of hypothalamic neurons in the rat. 1986 Jpn. J. Physiol. pmid:3022048
MacIntyre DE et al. Receptors and receptor mechanisms of endogenous platelet stimulatory and inhibitory mediators. 1986 Agents Actions Suppl. pmid:3028106
Keeting PE et al. Rat lens prostaglandin biosynthesis during galactose-induced cataractogenesis. 1986 Exp. Eye Res. pmid:3028846
Tanaka A et al. Antiherpetic action of prostaglandin D2. 1986 Prostaglandins Leukot Med pmid:3029784
Santoro MG et al. PGJ2, a new antiviral prostaglandin: inhibition of Sendai virus replication and alteration of virus protein synthesis. 1987 J. Gen. Virol. pmid:3033130
Yamamoto N et al. Mechanism of inhibition of herpes simplex virus replication by delta 7-prostaglandin A1 and delta 12-prostaglandin J2. 1987 Biochem. Biophys. Res. Commun. pmid:3040001
Ujihara M et al. Biochemical and immunological demonstration of prostaglandin D2, E2, and F2 alpha formation from prostaglandin H2 by various rat glutathione S-transferase isozymes. 1988 Arch. Biochem. Biophys. pmid:3041912
Fukushima M [Prostaglandin J2--anti-tumor activity and mechanism of action]. 1988 Nippon Rinsho pmid:3043050
Hayaishi O Sleep-wake regulation by prostaglandins D2 and E2. 1988 J. Biol. Chem. pmid:3049580
Moore PK et al. Effect of fibrinopeptides A and B on human and rat platelet aggregation in vitro. 1988 Eur. J. Pharmacol. pmid:3053211
Hirata Y et al. Occurrence of 9-deoxy-delta 9,delta 12-13,14-dihydroprostaglandin D2 in human urine. 1988 J. Biol. Chem. pmid:3053696
Yamamoto K et al. Muramyl dipeptide-elicited production of PGD2 from astrocytes in culture. 1988 Biochem. Biophys. Res. Commun. pmid:3056405
Schleimer RP et al. Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids. 1986 J. Immunol. pmid:3082976
Watanabe K [PGF synthetase]. 1986 Seikagaku pmid:3084680
Burrall B and Ziboh VA Increased biosynthesis of lipoxygenase products by UVB-irradiated guinea pig epidermis: evidence of a cyclooxygenase inhibitor. 1986 J. Invest. Dermatol. pmid:3086462
Saito H et al. Bio-synthesis of PGD2 and TXB2 by rabbit blood monocytes. 1986 Prostaglandins pmid:3086936
Hickok NJ et al. Characterization of prostaglandin endoperoxide synthase from a human cell line. 1986 Biochim. Biophys. Acta pmid:3087430
Kriseman T et al. Analysis of airway responses to A23187 in the cat. 1986 J. Pharmacol. Exp. Ther. pmid:3095538
Ruzicka T and Auböck J Arachidonic acid metabolism in guinea pig Langerhans cells: studies on cyclooxygenase and lipoxygenase pathways. 1987 J. Immunol. pmid:3098849
Shimizu Y et al. Cycloheximide reduces PGD2 or delta 12-PGJ2 cytotoxicity on NCG cells. 1986 Prostaglandins pmid:3099333
Brown MS et al. Arachidonic acid metabolites during nasal challenge. 1987 Arch. Otolaryngol. Head Neck Surg. pmid:3099812
Chiabrando C et al. Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor. 1987 Cancer Res. pmid:3100032
Anton RF and Randall CL Central nervous system prostaglandins and ethanol. 1987 Alcohol. Clin. Exp. Res. pmid:3105343
Rodriguez R et al. Effect of nimodipine on arachidonic acid metabolites after subarachnoid hemorrhage. 1987 Acta Neurol. Scand. pmid:3120489
Ujihara M et al. Prostaglandin D2 formation and characterization of its synthetases in various tissues of adult rats. 1988 Arch. Biochem. Biophys. pmid:3124755
Lahoua Z et al. Serum-induced arachidonic acid release and prostaglandin biosynthesis are potentiated by oxygenated sterols in NRK 49F cells. 1988 Biochim. Biophys. Acta pmid:3124881
Kuiper J et al. Identification of prostaglandin D2 as the major eicosanoid from liver endothelial and Kupffer cells. 1988 Biochim. Biophys. Acta pmid:3126817
Altin JG and Bygrave FL Prostaglandin F2 alpha and the thromboxane A2 analogue ONO-11113 stimulate Ca2+ fluxes and other physiological responses in rat liver. Further evidence that prostanoids may be involved in the action of arachidonic acid and platelet-activating factor. 1988 Biochem. J. pmid:3128268
Kawata R et al. Prostaglandin synthesis by the cochlea. 1988 Prostaglandins pmid:3129756
Rodriguez y Baena R et al. A study on cisternal CSF levels of arachidonic acid metabolites after aneurysmal subarachnoid hemorrhage. 1988 J. Neurol. Sci. pmid:3132538
Parsons WG and Roberts LJ Transformation of prostaglandin D2 to isomeric prostaglandin F2 compounds by human eosinophils. A potential mast cell-eosinophil interaction. 1988 J. Immunol. pmid:3139758
Yue TL and Mai K [Effects of protein malnutrition on the metabolism of arachidonic acid in the rat stomach and spleen]. 1988 Zhongguo Yao Li Xue Bao pmid:3142210
Kuiper J et al. The induction of glycogenolysis in the perfused liver by platelet activating factor is mediated by prostaglandin D2 from Kupffer cells. 1988 Biochem. Biophys. Res. Commun. pmid:3144970
Fukui A et al. Effects of prostaglandin D2 and omeprazole on indomethacin-induced gastric ulcers in rats. 1988 Clin. Exp. Pharmacol. Physiol. pmid:3149561
Vigano T et al. Prostaglandin synthetase inhibition and formation of lipoxygenase products in immunologically challenged normal human lung parenchyma. 1988 Eicosanoids pmid:3152489
Rocklin RE et al. Decreased sensitivity of atopic mononuclear cells to prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2). 1985 J. Immunol. pmid:3160784
Knepel W et al. Inhibition by prostaglandin E2 of the release of vasopressin and beta-endorphin from rat pituitary neurointermediate lobe or medial basal hypothalamus in vitro. 1985 J. Endocrinol. pmid:3160802
Robin JL et al. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids. 1985 J. Immunol. pmid:3161947
Suzuki K et al. Inhibition of human gingival carcinoma cell growth by prostaglandins. 1988 Gen. Pharmacol. pmid:3162424
Casteleijn E et al. Prostaglandin D2 mediates the stimulation of glycogenolysis in the liver by phorbol ester. 1988 Biochem. J. pmid:3162673
Ishioka C et al. Inhibitory effects of prostaglandin A2 on c-myc expression and cell cycle progression in human leukemia cell line HL-60. 1988 Cancer Res. pmid:3162825
Soifer SJ et al. Effects of prostaglandin D2 on pulmonary arterial pressure and oxygenation in newborn infants with persistent pulmonary hypertension. 1988 J. Pediatr. pmid:3162978
Wasserman SI Basic mechanisms in asthma. 1988 Ann Allergy pmid:3163472
Sonoki H et al. [Effects of 3,4-diaminopyridine on the contractions of guinea-pig tracheal smooth muscle induced by histamine and prostaglandin D2]. 1988 Nippon Yakurigaku Zasshi pmid:3163668
Onoe H et al. Prostaglandin D2, a cerebral sleep-inducing substance in monkeys. 1988 Proc. Natl. Acad. Sci. U.S.A. pmid:3163802
Foreman D et al. Anhydrolevuglandin D2 inhibits the uterotonic activity of prostaglandins F2 alpha and D2. 1988 Prostaglandins pmid:3163807
Shohami E et al. Experimental closed head injury in rats: prostaglandin production in a noninjured zone. 1988 Neurosurgery pmid:3164097